Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - BIO BRIDGE SCIENCE INC | Financial_Report.xls |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q/A
(Amendment No. 1)
x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended: June 30, 2011
or
¨ TRANSITION REPORT PURSUANT TO SECTION 13 0R 15(D) OF THE SECURITIES EXCHANGE ACT
OF 1934
For the transition period from _______ to _______
Commission File Number: 000-51497
BIO-BRIDGE SCIENCE, INC.
(Exact name of registrant as specified in its charter)
|
Delaware
|
20-1802936
|
|
(State or other jurisdiction of incorporation or organization)
|
(IRS Employer Identification No.)
|
|
1801 South Meyers Road, Suite 220, Oakbrook Terrace, Illinois, 60181
|
|
|
(Address of principal executive offices, Zip Code)
|
|
|
(630) 613-9687
|
|
|
(Issuer's telephone number including area code)
|
|
Check whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ¨ No ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
|
Large accelerated filer ¨
|
Accelerated filer ¨
|
Non-accelerated filer ¨
|
Smaller Reporting Company x
|
Indicate by check mark whether the registrant is a shell company: Yes ¨ No x
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.
The purpose of this Amendment No. 1 to Bio-Bridge Science, Inc.’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2011, filed with the Securities and Exchange Commission on August 15, 2011, is solely to furnish Exhibit 101 to the Form 10-Q. Exhibit 101 provides the financial statements and related notes from the Form 10-Q formatted in XBRL (eXtensible Business Reporting Language). No other changes have been made to the Form 10-Q. This Amendment does not reflect events that may have occurred subsequent to the original filing date.
|
3.1(i)*
|
Certificate of incorporation of the registrant, as currently in effect
|
|
3.1(ii)*
|
Bylaws of the registrant, as currently in effect
|
|
3.1(iii)**
|
Certificate of Designation of Series A Preferred Stock
|
|
31.1***
|
Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
31.2***
|
Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
32***
|
Certifications of Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of Sarbanes-Oxley Act of 2002
|
|
101****
|
The following materials from the Quarterly Report of Bio-Bridge Science, Inc. on Form 10-Q, filed on August 15, 2011, for the quarter ended June 30, 2011, formatted in XBRL (eXtensible Business Reporting Language): (i) Condensed Consolidated Balance Sheets as of June 30, 2011 (Unaudited) and December 31, 2010, (ii) Unaudited Condensed Consolidated Statements of Operations for the three and six months ended June 30, 2011 and 2010, (iii) Unaudited Condensed Consolidated Statements of Changes in Equity for the six months ended June 30, 2011, (iv) Unaudited Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2011 and 2010, (v) Notes to the Unaudited Condensed Consolidated Financial Statements, tagged as blocks of text.
|
* Previously filed with the Securities and Exchange Commission pursuant to Registration Statement No. 333-121786.
** Previously filed as an exhibit to the Registrant's Form 10-KSB for its year ended December 31, 2006.
*** Previously filed as an exhibit to the original Quarterly Report on Form 10-Q filed August 15, 2011.
**** Furnished herewith.
SIGNATURES
In accordance with Section 13 or 15(d) of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Bio-Bridge Science, Inc.
Date: August 26, 2011
|
/s/ Dr. Liang Qiao
|
|
By: Dr. Liang Qiao
Chief Executive Officer
(Principal Executive Officer)
|